Alzheimer’s

Dementia patients ‘face unfair care tax’

The dementia charities have long been campaigning against the financial burden placed  on families in having to pay for care of loved ones with dementia. Shocking new figures from the London School of Economics and Kings College London on behalf of The Alzheimer’s Society  now reveal the true scale of the problem. BBC News Health(…)

More

Research into the effects of cataract eye surgery on dementia patients

New clinical trial results from the US, reported at the Alzheimer’s Association International Conference® in July, suggest that cataract surgery for people with Alzheimer’s disease and other dementias not only improves vision but can also slow down decline in cognition. The clinical trials, currently being undertaken in Cleveland, Ohio, were set up to determine the(…)

More

How useful are complimentary therapies in the treatment of dementia?

The Alzheimer’s Society reported in 2013 that 1 in 4 individuals coping with dementia had made use of complimentary or alternative therapies in the previous year. With the possible side effects of conventional medications well documented, and individuals wanting to find any effective method to deal with the results of their dementia, it is easy(…)

More

Terry Pratchett: Those of us with dementia need a little help from our friends

Terry Pratchett –  OBE, best selling author, campaigner and fund raiser-  has been tireless in his quest to raise awareness about dementia since his diagnosis of early-onset Alzheimer’s disease back in December 2007. Suffering from a rare form of the disease, posterior cortical atrophy, which affects his motor skills in particular, he has never stopped(…)

More

Blood Test breakthrough in the hunt for a cure to Alzheimer’s disease.

A blood test that can predict the onset of  Alzheimer’s disease in patients with mild cognitive impairment, much earlier than current methods, has been developed by British scientists. An international collaboration led by scientists from King’s College, London and Proteome Sciences, a UK biotechnology company, hope that the test could provide a breakthrough in the(…)

More